-
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
on behalf of the Dutch CAR-T Tumorboard Consortium, 1 Sept 2023, In: Cancers. 15, 17, 4334.Research output: Contribution to journal › Article › Academic › peer-review
-
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
Spanjaart, A. M., Pennings, E. R. A., Kos, M., Mutsaers, P. G. N. J., Lugtenburg, P. J., van Meerten, T., van Doesum, J. A., Minnema, M. C., Jak, M., van Dorp, S., Vermaat, J. S. P., van der Poel, M. W. M., van Oijen, M. G. H., Kuipers, M. T., Nijhof, I. S. & Kersten, M. J., 1 Mar 2023, In: JCO oncology practice. 19, 3, p. E407-E416Research output: Contribution to journal › Article › Academic › peer-review
-
Cellular therapy in lymphoma
Sureda, A., Lugtenburg, P. J., Kersten, M. J., Subklewe, M., Spanjaart, A., Shah, N. N., Kerbauy, L. N., Roddie, C., Pennings, E. R. A., Mahuad, C., Poon, M., Hendricks, C. L., Kamdar, M. & Jacobson, C., 2023, (E-pub ahead of print) In: Hematological oncology.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications